Co-developed by NYU Langone and Dana-Farber, the Solavia platform integrates EHR workflows, decision support, and pathway tracking for APPs and PAs.
|Articles|May 20, 2011
Juanita Madison Describes the Provenge Treatment Process
Author(s)Juanita Madison, MN, RN
Juanita Madison from Seattle Cancer Care Alliance Describes the Provenge Treatment Process
Advertisement
Lead researcher Juanita Madison, MN, RN, AOCN from the Seattle Cancer Care Alliance (SCCA) discusses some of the findings from her research on the complexity of the provenge treatment process and how it involves several multidisciplinary teams as the immune cells go from leukapheresis, to a Dendreon manufacturing facility, and then back to the patient.
View more videos of
Advertisement
Related to this article
The FDA expands accelerated approval for sevabertinib to frontline HER2-mutant NSCLC, highlighting a need for vigilant nursing management of diarrhea.
FDA approves camizestrant for ESR1-mutated advanced breast cancer, tasking oncology nurses with guiding patients through ctDNA-based surveillance.
Dana Delaski, MSN, FNP-BC, shares insights on how once-daily ruxolitinib, self-injected rusfertide, and givinostat will transform PV clinic workflows.
The FDA has approved oral iberdomide (Zenbexus) for relapsed/refractory multiple myeloma, offering patients a highly potent, accessible therapy.
Oncology clinicians must actively champion NCCN guidelines as a critical pillar of breast cancer survivorship care,
With daraxonrasib approved for metastatic pancreatic cancer, Yolanda Justal, APRN, discusses essential nursing workflows for home-based care.
Beth Sandy, CRNP, of Penn Medicine explains how oncology nurses and pharmacists collaborate to manage financial toxicity and secure oral therapies.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Oncology Experts Discuss On-Body Subcutaneous Isatuximab in Multiple Myeloma
2
Why Using AI to Interpret Mammogram Results Can Cause Unnecessary Panic
3
FDA Approves sNDA for Taletrectinib in ROS1+ NSCLC
4
Prostate Cancer Care: ADT Management and APP Guidance
5